share_log

浙江圣达生物药业股份有限公司关于2023年度向特定对象发行A股股票预案(修订稿)披露的提示性公告

An indicative announcement by Zhejiang Shengda Biopharmaceutical Co., Ltd. on the disclosure of the 2023 plan to issue A-shares to specific targets (revised draft)

SZSI ·  Feb 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more